Revolutionizing Maternal Diagnostics with Biotics AI

Table of Contents

1. Introduction
2. The Growing Problems in Pregnancy Care
   • The Shortage of Obstetricians
   • Increasing Rate of Pregnancy Complications
   • New Legislation's Impact on Maternal Diagnostics
3. The Misdiagnosis of Fetal Malformations
   • Errors by Ultrasound Operators
   • Lack of Access to Diagnostic Ultrasound
4. Introducing Biotics AI for Early Detection of Anomalies
   • Biotics AI: Vendor-Agnostic Cloudbased Software
   • Localization of Anomalies
   • Ensuring Completeness of Screening
   • Extracting Information and Generating Reports with AI
5. Clinical Studies and Efficiency Gains with Biotics AI
   • Improved Completeness Rate of Screenings
   • Time Savings on Documentation
   • Increased Patient Volume and ROI
6. The Expert Team behind Biotics AI
   • Obstetricians and Machine Learning Engineers
   • Award-Winning Research in Prenatal Diagnostics and AI
7. Success Story in Australia and New Zealand
   • Recruitment of Opinion Leaders and Pilots
   • Recognition in Startup Pitch Competition
8. The Unfair Advantage of Biotics AI
   • Continuously Growing Data Mode
   • Expansion into Adjacent Markets
9. Funding Needs and Mission to Fix Prenatal Care Crisis

Detecting Anomalies in Pregnancy Care with Biotics AI

Pregnancy care has always been a crucial aspect of maternal health. However, in recent years, the field has faced numerous challenges, ranging from a shortage of obstetricians to an increasing rate of pregnancy complications. Additionally, new legislation has negatively impacted the use of maternal diagnostics, making it even more difficult to identify and prevent problems during pregnancy. This has resulted in preventable complications and the misdiagnosis of fetal malformations, leading to tragic outcomes for both mothers and their unborn babies.

The Growing Problems in Pregnancy Care

The Shortage of Obstetricians

👉 The Impact on Maternal Care The shortage of obstetricians is a pressing issue in pregnancy care. With an increasing demand for prenatal services and a limited number of qualified professionals, the quality of maternal care is at risk. This shortage not only places a burden on the existing healthcare system but also leads to preventable complications and poor maternal outcomes.

Increasing Rate of Pregnancy Complications

👉 Rising Challenges in Maternal Health Another major challenge in pregnancy care is the alarming increase in the rate of pregnancy complications. Factors such as advanced maternal age, pre-existing medical conditions, and lifestyle choices have contributed to this rise. Without proactive measures to address these complications, the health and well-being of both mother and baby are compromised.

New Legislation's Impact on Maternal Diagnostics

👉 Obstacles in Early Detection Recent legislation changes have posed additional obstacles in the field of maternal diagnostics. New restrictions and regulations have made it more difficult for healthcare professionals to identify and diagnose potential problems early on. This has resulted in a delayed or inaccurate diagnosis, leading to a significant impact on the overall quality of prenatal care.

The Misdiagnosis of Fetal Malformations

Errors by Ultrasound Operators

👉 The Role of Human Error One of the primary reasons for the misdiagnosis of fetal malformations is the potential for errors by ultrasound operators. Even experienced professionals may make mistakes due to factors such as fatigue, lack of training, or limited access to updated protocols. These errors can have devastating consequences, as they may lead to incorrect treatment plans or the failure to detect anomalies altogether.

Lack of Access to Diagnostic Ultrasound

👉 Global Disparity in Healthcare A significant global issue contributing to the misdiagnosis of fetal malformations is the lack of access to diagnostic ultrasound. Shockingly, there are approximately 107 million mothers worldwide who do not have access to the minimum standard of diagnostic ultrasound. This lack of access leaves a vast majority of fetal malformations undetected, compromising the health and well-being of both mother and baby.

Introducing Biotics AI for Early Detection of Anomalies

Biotics AI: Vendor-Agnostic Cloudbased Software

👉 Revolutionizing Maternal Diagnostics Biotics AI is a groundbreaking vendor-agnostic cloudbased software that aims to revolutionize maternal diagnostics. By leveraging the power of artificial intelligence, Biotics AI can process ultrasound scans and detect anomalies with unprecedented accuracy and efficiency. Its cloud-based nature ensures that obstetricians can access the system from anywhere, eliminating limitations posed by local hardware or software.

Localization of Anomalies

👉 Enhancing Detection Capabilities Biotics AI excels at localizing anomalies within ultrasound scans. By analyzing the scanned images, the software can precisely pinpoint areas of concern, ensuring that no potential anomalies go unnoticed. This localization capability is a game-changer, as it significantly improves the overall efficiency and effectiveness of prenatal screenings.

Ensuring Completeness of Screening

👉 A Comprehensive Approach Biotics AI goes beyond just anomaly detection. It provides a feedback loop to ensure the overall completeness of the screening process. By validating the appropriate capture of over 90 anatomical views and structures, the software guarantees that obstetricians have a diagnostically viable and safe screening. This comprehensive approach reduces the chances of missing critical information and offers peace of mind to both healthcare providers and patients.

Extracting Information and Generating Reports with AI

👉 Efficiency and Accuracy Combined Another key feature of Biotics AI is its ability to extract information from ultrasound scans and automatically generate reports and documentation. This saves valuable time for physicians, allowing them to focus more on patient care rather than administrative tasks. Moreover, the AI-powered reporting system adds an extra layer of accuracy and efficiency to the overall diagnostic process.

Clinical Studies and Efficiency Gains with Biotics AI

Improved Completeness Rate of Screenings

👉 Enhancing Diagnostic Quality Clinical studies have shown the significant impact of Biotics AI on the overall completeness rate of ultrasound screenings. Obstetricians who historically performed poor quality scans witnessed a 20% increase in their screening completeness when using Biotics AI. This improvement ensures that no crucial anatomical views or structures are missed, enhancing the diagnostic quality and providing better insights into maternal and fetal health.

Time Savings on Documentation

👉 Streamlining Administrative Tasks Apart from enhancing diagnostic quality, Biotics AI also brings significant time savings to obstetricians. With the AI-powered automation of reports and documentation, healthcare professionals can save an average of eight minutes per patient. This time efficiency not only allows physicians to see more patients but also alleviates the burden of excessive paperwork, resulting in improved overall productivity and job satisfaction.

Increased Patient Volume and ROI

👉 The Financial Benefits of Biotics AI The combination of improved diagnostic completeness and time savings on documentation leads to increased patient volume for healthcare institutions implementing Biotics AI. This increased patient volume can provide a return on investment (ROI) of up to $9,000 per user per month. The financial benefits, coupled with the enhanced quality of care, make Biotics AI an attractive solution for hospitals and clinics.

The Expert Team behind Biotics AI

Obstetricians and Machine Learning Engineers

👉 A Collaboration of Medical and Technological Expertise Biotics AI is the result of a collaboration between a world-class team of obstetricians and machine learning engineers. The team members have a rich background in delivering award-winning research in prenatal diagnostics and pioneering AI projects. With expertise from renowned institutions such as IBM Watson, Oracle, Kaiser Permanente, and the University of Pennsylvania, the team is well-equipped to tackle the challenges of maternal care.

Award-Winning Research in Prenatal Diagnostics and AI

👉 A Track Record of Excellence The expertise of the Biotics AI team is evidenced by their previous success in the field of prenatal diagnostics and AI. They have been involved in groundbreaking research projects and have received recognition for their contributions. This track record of excellence ensures that Biotics AI is built on a solid foundation of scientific knowledge and technological innovation.

Success Story in Australia and New Zealand

Recruitment of Opinion Leaders and Pilots

👉 Gaining Traction in the Region When Biotics AI entered the Australian market, they faced a lack of initial traction. However, within 12 weeks, they successfully recruited the two leading opinion leaders in prenatal diagnostics and ultrasound. This achievement allowed them to initiate three pilots across Australia and New Zealand, showcasing the effectiveness of their technology and garnering attention from other healthcare institutions.

Recognition in Startup Pitch Competition

👉 Global Acclaim for Biotics AI Biotics AI's success expanded beyond the Oceanian region when they participated in the world's largest startup pitch competition in San Francisco. Out of 3,000 competing startups, Biotics AI emerged as the winner, gaining recognition for their innovative solution to the prenatal care crisis. This global acclaim further solidified their position as a leader in AI diagnostics for reproductive health.

The Unfair Advantage of Biotics AI

Continuously Growing Data Mode

👉 A Data-Rich Environment Biotics AI's unfair advantage lies in its continuously growing data mode. With access to over 8 million ultrasound images, they have a vast dataset to train and refine their algorithms. This wealth of data allows them to develop new algorithms for various indications, which in turn expands their capabilities beyond prenatal care. Biotics AI's data-driven approach ensures ongoing advancements and positions them as the go-to AI diagnostics platform for reproductive health.

Expansion into Adjacent Markets

👉 Bridging the Gaps in Healthcare The continuously growing data mode also allows Biotics AI to expand into adjacent markets such as gynecology, urology, and neology. By leveraging their expertise and technological infrastructure, Biotics AI aims to bridge the gaps in healthcare and provide AI diagnostics solutions in other fields related to reproductive health. This expansion not only broadens their impact but also opens new avenues for growth and innovation.

Funding Needs and Mission to Fix Prenatal Care Crisis

Biotics AI is currently seeking $3 million in funding to reach their goal of $1 million in recurring revenue (RR). They are actively looking for like-minded investors who share their vision and want to contribute to fixing the prenatal care crisis. By investing in Biotics AI, backers can be part of a groundbreaking solution that improves maternal and fetal health outcomes, addresses the shortage of obstetricians, and revolutionizes the field of reproductive health diagnostics.

Highlights

• Biotics AI revolutionizes maternal diagnostics with its vendor-agnostic cloudbased software.
• It detects anomalies earlier and with greater efficiency, saving time for clinicians and improving diagnostic accuracy.
• Biotics AI ensures the completeness of ultrasound screenings, minimizing the chances of missing critical information.
• Obstetricians using Biotics AI witnessed a 20% increase in the completeness rate of their scans.
• The software saves an average of eight minutes per patient on documentation, leading to increased patient volume and ROI.
• The Biotics AI team consists of expert obstetricians and machine learning engineers with a history of award-winning research.
• Biotics AI garnered traction in Australia and New Zealand, Recruiting opinion leaders and initiating pilots.
• Their continuously growing data mode allows them to expand into adjacent markets and advance their AI algorithms.
• Biotics AI is seeking $3 million in funding to fix the prenatal care crisis and improve maternal and fetal health outcomes.

FAQ

Q: How does Biotics AI ensure the accuracy of its anomaly detection? A: Biotics AI leverages artificial intelligence to analyze ultrasound scans with unprecedented accuracy, ensuring the early detection of anomalies. Its vendor-agnostic cloudbased software uses advanced algorithms to localize anomalies within the scans, providing obstetricians with precise information for diagnosis and treatment planning.

Q: Can Biotics AI be integrated into existing healthcare systems? A: Yes, Biotics AI is designed to be integrated seamlessly into existing healthcare systems. Its cloudbased nature allows obstetricians to access the software from anywhere, eliminating the need for specific hardware or software installations. This makes the adoption process smoother for healthcare institutions.

Q: How does Biotics AI benefit healthcare institutions financially? A: Biotics AI brings financial benefits to healthcare institutions through increased patient volume and time savings. The improved efficiency of screenings and automation of documentation allow obstetricians to see more patients, ultimately leading to a higher return on investment. Additionally, the software streamlines administrative tasks, reducing the burden of paperwork and enhancing overall productivity.

Q: Does Biotics AI only focus on prenatal care? A: While Biotics AI initially focuses on prenatal care, its continuously growing data mode allows for expansion into adjacent markets such as gynecology, urology, and neology. This diversification broadens its impact and positions it as a comprehensive AI diagnostics platform for reproductive health.

Q: How can potential investors contribute to Biotics AI's mission? A: Potential investors can contribute to Biotics AI's mission by providing funding support. With their investment, they can join the journey to fix the prenatal care crisis, improve maternal and fetal health outcomes, and revolutionize the field of reproductive health diagnostics.